APVO
APVO
NASDAQ · Biotechnology

Aptevo Therapeutics Inc

$1.91
+0.02 (+1.06%)
As of Sep 28, 10:43 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,379.1% upside
Low Target $22.50
Average Target $28.25
High Target $48.31
Current Price $1.91
Current
$1.91
Target
$28.25
$22.50 $28.25 avg $48.31
Scenario Analysis
Bear Case
$22.50
1,078.0%
Low target
Base Case
$28.25
+1,379.1%
Avg target
Bull Case
$48.31
+2,429.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$35.64
-94.6% from high
52-Week Low
$1.37
+39.4% from low
Target vs 52W High
$28.25
-20.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%